Management of endocrine disease: Postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantation by Mihai, R, Thakker, RV

Genetics of kidney stone disease by Howles, SA, Thakker, RV

Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway by Hannan, FM, Olesen, MK, Thakker, RV

The role of DNA methylation in human pancreatic neuroendocrine tumours by English, KA, Thakker, RV, Lines, KE

Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches by Stevenson, M, Lines, KE, Thakker, RV

Hypercalcemic disorders in children by Stokes, VJ, Nielsen, MF, Hannan, FM, Thakker, RV

Genetics of skeletal disorders by Hannan, FM, Newey, PJ, Whyte, MP, Thakker, RV

Genetics of monogenic disorders of calcium and bone metabolism by Newey, PJ, Hannan, FM, Wilson, A, Thakker, RV

Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs) by Grozinsky-Glasberg, S, Lines, KE, Avniel-Polak, S, Bountra, C, Thakker, RV

Biased calcium-sensing receptor signalling in the pathogenesis of kidney stone disease by Wiberg, A, Goldsworthy, M, Turney, BW, Furniss, D, Thakker, RV, Howles, S

Endocrinology in the time of COVID-19: Clinical management of neuroendocrine neoplasms (NENs) by Casey, RT, Valk, GD, Schalin-Jäntti, C, Grossman, AB, Thakker, RV

The Bartter-Gitelman spectrum: 50-year follow-up with revision of diagnosis after whole-genome sequencing  by Stevenson, M, Pagnamenta, AT, Mack, HG, Savige, J, Giacopuzzi, E, Lines, KE, Taylor, JC, Thakker, RV

Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia by Stevenson, M, Pagnamenta, AT, Reichart, S, Philpott, C, Lines, KE, Gorvin, CM, Lhotta, K, Taylor, JC, Thakker, RV

Calcilytic NPSP795 increases plasma calcium and PTH in an autosomal dominant hypocalcemia type 1 mouse model by Hannan, FM, Gorvin, CM, Babinsky, VN, Olesen, MK, Stewart, M, Wells, S, Cox, RD, Nemeth, EF, Thakker, RV

Multiple endocrine neoplasia type 1 (MEN1) phenocopy due to a cell cycle division 73 (CDC73) variant by Lines, KE, Nachtigall, LB, Dichtel, LE, Cranston, T, Boon, H, Zhang, X, Kooblall, KG, Stevenson, M, Thakker, RV

Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population by Dershem, R, Gorvin, CM, Metpally, RPR, Krishnamurthy, S, Smelser, DT, Hannan, FM, Carey, DJ, Thakker, RV, Breitwieser, GE

Neonatal hypocalcemic seizures in offspring of a mother with familial hypocalciuric hypercalcemia type 1 (FHH1) by Dharmaraj, P, Gorvin, CM, Soni, A, Nelhans, ND, Olesen, MK, Boon, H, Cranston, T, Thakker, RV, Hannan, FM

Hypoxia stimulates angiogenesis and a metabolic switch in human parathyroid adenoma cells by Lines, KE, Stevenson, M, Mihai, R, Grigorieva, IV, Shariq, OA, Gaynor, KU, Jeyabalan, J, Javid, M, Thakker, RV

Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism by Cranston, T, Boon, H, Olesen, MK, Ryan, F, Shears, D, London, R, Rostom, H, Elajnaf, T, Thakker, RV, Hannan, FM

Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells by Lines, KE, Filippakopoulos, P, Stevenson, M, Müller, S, Lockstone, HE, Wright, B, Knapp, S, Buck, D, Bountra, C, Thakker, RV